Global Next-Generation Sequencing (NGS) Services 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01252797

Publication Date:

January 28, 2025

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Next-Generation Sequencing (NGS) Services market size is predicted to grow from US$ 4797 million in 2025 to US$ 11670 million in 2031; it is expected to grow at a CAGR of 16.0% from 2025 to 2031.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
The 鈥淣ext-Generation Sequencing (NGS) Services Industry Forecast鈥� looks at past sales and reviews total world Next-Generation Sequencing (NGS) Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Next-Generation Sequencing (NGS) Services sales for 2025 through 2031. With Next-Generation Sequencing (NGS) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Sequencing (NGS) Services industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Sequencing (NGS) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Sequencing (NGS) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Next-Generation Sequencing (NGS) Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Sequencing (NGS) Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Sequencing (NGS) Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Sequencing (NGS) Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size (2020-2031)
2.1.2 Next-Generation Sequencing (NGS) Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Next-Generation Sequencing (NGS) Services by Country/Region (2020, 2024 & 2031)
2.2 Next-Generation Sequencing (NGS) Services Segment by Type
2.2.1 Targeted Sequencing
2.2.2 Whole Exome Sequencing
2.2.3 Whole Genome Sequencing
2.3 Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type
2.3.1 Next-Generation Sequencing (NGS) Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Next-Generation Sequencing (NGS) Services Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Biopharma Companies
2.4.3 Academic & Research Organizations
2.4.4 Others
2.5 Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application
2.5.1 Next-Generation Sequencing (NGS) Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Player
3.1 Next-Generation Sequencing (NGS) Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Next-Generation Sequencing (NGS) Services Revenue by Player (2020-2025)
3.1.2 Global Next-Generation Sequencing (NGS) Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Next-Generation Sequencing (NGS) Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Next-Generation Sequencing (NGS) Services by Region
4.1 Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Next-Generation Sequencing (NGS) Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Next-Generation Sequencing (NGS) Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Next-Generation Sequencing (NGS) Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Next-Generation Sequencing (NGS) Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Next-Generation Sequencing (NGS) Services by Region (2020-2025)
8.2 Middle East & Africa Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Next-Generation Sequencing (NGS) Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Next-Generation Sequencing (NGS) Services 麻豆原创 Forecast
10.1 Global Next-Generation Sequencing (NGS) Services Forecast by Region (2026-2031)
10.1.1 Global Next-Generation Sequencing (NGS) Services Forecast by Region (2026-2031)
10.1.2 Americas Next-Generation Sequencing (NGS) Services Forecast
10.1.3 APAC Next-Generation Sequencing (NGS) Services Forecast
10.1.4 Europe Next-Generation Sequencing (NGS) Services Forecast
10.1.5 Middle East & Africa Next-Generation Sequencing (NGS) Services Forecast
10.2 Americas Next-Generation Sequencing (NGS) Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.2.2 Canada 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.2.3 Mexico 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.2.4 Brazil 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.3 APAC Next-Generation Sequencing (NGS) Services Forecast by Region (2026-2031)
10.3.1 China Next-Generation Sequencing (NGS) Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.3.3 Korea 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.3.4 Southeast Asia 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.3.5 India 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.3.6 Australia 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.4 Europe Next-Generation Sequencing (NGS) Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.4.2 France 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.4.3 UK 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.4.4 Italy 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.4.5 Russia 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.5 Middle East & Africa Next-Generation Sequencing (NGS) Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.5.2 South Africa 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.5.3 Israel 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.5.4 Turkey 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
10.6 Global Next-Generation Sequencing (NGS) Services Forecast by Type (2026-2031)
10.7 Global Next-Generation Sequencing (NGS) Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Next-Generation Sequencing (NGS) Services Forecast
11 Key Players Analysis
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Information
11.1.2 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Offered
11.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Eurofins Scientific Main Business Overview
11.1.5 Eurofins Scientific Latest Developments
11.2 Natera
11.2.1 Natera Company Information
11.2.2 Natera Next-Generation Sequencing (NGS) Services Product Offered
11.2.3 Natera Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Natera Main Business Overview
11.2.5 Natera Latest Developments
11.3 BGI
11.3.1 BGI Company Information
11.3.2 BGI Next-Generation Sequencing (NGS) Services Product Offered
11.3.3 BGI Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 BGI Main Business Overview
11.3.5 BGI Latest Developments
11.4 Illumina
11.4.1 Illumina Company Information
11.4.2 Illumina Next-Generation Sequencing (NGS) Services Product Offered
11.4.3 Illumina Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Illumina Main Business Overview
11.4.5 Illumina Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Next-Generation Sequencing (NGS) Services Product Offered
11.5.3 Roche Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Next-Generation Sequencing (NGS) Services Product Offered
11.6.3 LabCorp Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Information
11.7.2 Berry Genomics Next-Generation Sequencing (NGS) Services Product Offered
11.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Berry Genomics Main Business Overview
11.7.5 Berry Genomics Latest Developments
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Information
11.8.2 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Offered
11.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Brooks Life Sciences Main Business Overview
11.8.5 Brooks Life Sciences Latest Developments
11.9 Macrogen
11.9.1 Macrogen Company Information
11.9.2 Macrogen Next-Generation Sequencing (NGS) Services Product Offered
11.9.3 Macrogen Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Macrogen Main Business Overview
11.9.5 Macrogen Latest Developments
11.10 Personalis
11.10.1 Personalis Company Information
11.10.2 Personalis Next-Generation Sequencing (NGS) Services Product Offered
11.10.3 Personalis Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Personalis Main Business Overview
11.10.5 Personalis Latest Developments
11.11 Novogene
11.11.1 Novogene Company Information
11.11.2 Novogene Next-Generation Sequencing (NGS) Services Product Offered
11.11.3 Novogene Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Novogene Main Business Overview
11.11.5 Novogene Latest Developments
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Information
11.12.2 Genotypic Technology Next-Generation Sequencing (NGS) Services Product Offered
11.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Genotypic Technology Main Business Overview
11.12.5 Genotypic Technology Latest Developments
11.13 Dna Link
11.13.1 Dna Link Company Information
11.13.2 Dna Link Next-Generation Sequencing (NGS) Services Product Offered
11.13.3 Dna Link Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Dna Link Main Business Overview
11.13.5 Dna Link Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.